Browse > Article
http://dx.doi.org/10.15324/kjcls.2019.51.4.428

Carbapenemase-Producing Klebsiella oxytoca Detection Using Molecular Methods  

Yang, Byoung Seon (Department of Medical Laboratory Science, Jinju Health College)
Park, Ji Ae (Department of Medical Laboratory Science, Jinju Health College)
Publication Information
Korean Journal of Clinical Laboratory Science / v.51, no.4, 2019 , pp. 428-435 More about this Journal
Abstract
The rapid increase and dissemination of carbapene mases, such as Klebsiella pneumoniae carbapenemase (KPC), has become a major problem within the field of healthcare-related infection. There are few antibiotics to treat carbapenem-resistant Enterobacteriaceae (CRE) infections, so the identification of resistant bacterial mechanisms is critical to initiate infection control and conduct epidemiological research. A rapid and effective method for detecting KPC-producing bacteria is needed to avoid therapeutic failures and introduce measures to prevent and control the dissemination of these multi-resistant bacteria. During the study period, 31 isolates (seven isolates of Acinetobacter spp., six isolates of Morganella morganii, five isolates of Pseudomonas aeruginosa, five isolates of Proteus mirabilis, one isolate of Proteus vulgaris, two isolates of Enterobacter cloacae, one isolate of Enterobacter aerogenes, one isolate of Klebsiella pneumoniae, one isolate of Klebsiella oxytoca, one isolate of Serratia marcescens and one isolate of Escherichia coli) were identified by the VITEK. Gram negative rod bacteria were the most frequently isolated from urine (35.5%), blood (19.4%), sputum (16.1%), pus (9.7%), ascitic fluid (9.7%), tracheal aspirates (6.5%) and bile juice (3.2%). Analysis using the PCR method identified the blaKPC gene in the K. oxytoca1 strain, but the blaIMP, blaVIM and blaOXA-48 genes are not amplified. In conclusion, diagnosis using the PCR method can accurately and quickly diagnose KPC, thus establishing quick preventive measures to prevent the spread of KPC in hospitals.
Keywords
Carbapenem-resistant Enterobacteriaceae; Klebsiella oxytoca; Klebsiella pneumoniae carbapenemase;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Lodise TP, Bonine NG, Ye JM, Folse HJ, Gillard P. Development of a bedside tool to predict the probability of drug-resistant pathogens among hospitalized adult patients with gram-negative infections. BMC Infectious Diseases. 2019;19:718. https://doi.org/10.1186/s12879-019-4363-y   DOI
2 Gupta V, Ye G, Olesky M, Lawrence K, Murray J, Yu K. Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013-2017. BMC Infect Dis. 2019;19:742. https://doi.org/10.1186/s12879-019-4387-3   DOI
3 Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement M100-S27. Wayne, PA: Clinical Laboratory Standards Institute; 2017.
4 Bonomo RA, Burd EM, Conly J, Limbago BM, Poirel L, Segre JA, et al. Carbapenemase-producing organisms: a global scourge. Clin Infect Dis. 2018;66:1290-1297. https://doi.org/10.1093/cid/cix893   DOI
5 Bora A, Sanjana R, Jha BK, Mahaseth SN, Pokharel K. Incidence of metallo-beta-lactamase producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in central Nepal. BMC Res Notes. 2014;7:557. https://doi.org/10.1186/1756-0500-7-557   DOI
6 Monteiro J, Widen RH, Pignatari ACC, Kubasek C, Silbert S. Rapid detection of carbapenemase genes by multiplex real-time PCR. J Antimicrob Chemother. 2012;67:906-909. https://doi.org/10.1093/jac/dkr563   DOI
7 Doyle D, Peirano G, Lascols C, Lloyd T, Church DL, Pitout JD. Laboratory detection of Enterobacteriaceae that produce carbapenemases. J Clin Microbiol. 2012;50:3877-3880. https://doi.org/10.1128/JCM.02117-12   DOI
8 Roh KH, Lee CK, Sohn JW, Song W, Yong D, Lee K. Isolation of a Klebsiella pneumoniae isolate of sequence type 258 producing KPC-2 carbapenemase in Korea. Korean J Lab Med. 2011;31:298-301. https://doi.org/10.3343/kjlm.2011.31.4.298
9 Rhee JY, Park YK, Shin JY, Choi JY, Lee MY, Peck KR, et al. KPC producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea. Antimicrob Agents Chemother. 2010;54:2278-2279. https://doi.org/10.1128/AAC.00011-10   DOI
10 Bae IK, Kang HK, Jang IH, Lee W, Kim K, Kim JO, et al. Detection of carbapenemases in clinical Enterobacteriaceae isolates using the VITEK AST-N202 card. Infect Chemother. 2015;47:167-174. https://doi.org/10.3947/ic.2015.47.3.167   DOI
11 Jeong SH, Lee KM, Lee J, Bae IK, Kim JS, Kim HS, et al. Clonal and horizontal spread of the bla OXA-232 gene among Enterobacteriaceae in a Korean hospital. Diagn Microbiol Infect Dis. 2015;82:70-72. https://doi.org/10.1016/j.diagmicrobio.2015.02.001   DOI
12 Garg A, Garg J, Kumar S, Bhattacharya A, Agarwal S, Upadhyay GC. Molecular epidemiology & therapeutic options of carbapenem-resistant gram-negative bacteria. Indian J Med Res. 2019;149:285-289. https://doi.org/10.4103/ijmr.IJMR_36_18   DOI
13 Centers for Disease Control and Prevention. Office of infectious disease antibiotic resistance threats in the United States, 2013 [Internet]. Atlanta: Centers for Disease Control and Prevention; 2015 [cited 2019 August 28]. Available from: https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf.
14 Centers for Disease Control and Prevention. Patients with NDM-producing carbapenem-resistant Enterobacteriaceae (CRE) reported to the Centers for Disease Control and Prevention (CDC) as of December 2017, by state [Internet]. Atlanta: Centers for Disease Control and Prevention; 2017 [cited 2019August 28]. Available from: https://www.cdc.gov/hai/organisms/cre/trackingcre.html.
15 Rodriguez-Bano J, Gutierrez-Gutierrez B, Machuca I, Pascual A. Treatment of infections caused by extended-spectrum- beta-lactamase-, AmpC-, and carbapenemase-producing Enterobacteriaceae. Clin Microbiol Rev. 2018;31:1-42. https://doi.org/10.1128/CMR.00079-17
16 Park JW, Lee EJ, et al. Status of carbapenemase producing Enterobacteriaceae incidences in Korea, 2015-2016. Research report. Cheongju: Korea Centers for Disease Control and Prevention; 2017;10:1243-1247.
17 Go EB, Ju SJ, et al. Distribution of carbapenem-resistant Enterobacteriaceae (CRE) in Korea, 2017. Research report. Cheongju: Korea Centers for Disease Control and Prevention; 2018;11:1518-1522.
18 Weiner LM, Webb AK, Limbago B, Dudeck MA, Patel J, Kallen AJ, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety network at the Centers for Disease Control and Prevention, 2011-2014. Infect Control Hosp Epidemiol. 2016;37:1288-1301. https://doi.org/ 10.1017/ice.2016.174   DOI
19 Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. PT. 2015;40:277-283.
20 Sengupta S, Chattopadhyay MK, Grossart HP. The multifaceted roles of antibiotics and antibiotic resistance in nature. Front Microbiol. 2013;4:47. https://doi.org/10.3389/fmicb.2013.00047   DOI
21 Kim JE. Carbapenem-resistant Enterobacteriaceae in Korea. Hanyang Med Rev. 2018;38:99-102. https://doi.org/10.7599/hmr.2018.38.2.99   DOI
22 Centers for Disease Control and Prevention. FAQs about choosing and implementing a CRE definition [Internet]. Atlanta: Centers for Disease Control and Prevention; 2015 [cited 2019 August 28]. Available from: https://www.cdc.gov/hai/organisms/cre/definition.html.
23 Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18:318-327. https://doi.org/10.1016/S1473-3099(17)30753-3   DOI
24 McCann E, Srinivasan A, DeRyke CA, DePestel DD, Murray J, Gupta V. Carbapenem-nonsusceptible gram-negative pathogens in ICU and non-ICU settings in US hospitals in 2017: a multicenter study. Open Forum Infect Dis. 2018;5:ofy241. https://doi.org/10.1093/ofid/ofy241   DOI
25 Hauck C, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, et al. Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections. Clin Microbiol Infect. 2016;22:513-519. https://doi.org/10.1016/j.cmi.2016.01.023   DOI
26 Potter RF, D'Souza AW, Dantas G. The rapid spread of carbapenem-resistant Enterobacteriaceae. Drug Resist Updat. 2016;29:30-46. https://doi.org/10.1016/j.drup.2016.09.002   DOI
27 Iovleva A, Doi Y. Carbapenem-resistant Enterobacteriaceae. Clin Lab Med. 2017;37:303-315. https://doi.org/10.1016/j.cll.2017.01.005   DOI
28 Lee HJ, Lee DG. Carbapenem-resistant Enterobacteriaceae: recent updates and treatment strategies. J Korean Med Assoc. 2018;61:281-289. https://doi.org/10.5124/jkma.2018.61.4.281   DOI
29 Tamma PD, Goodman KE, Harris AD, Tekle T, Roberts A, Taiwo A, et al. Comparing the outcomes of patients with carbapenemase-producing and non-carbapenemase producing carbapenem- resistant Enterobacteriaceae bacteremia. Clin Infect Dis. 2017;64:257-264. https://doi.org/10.1093/cid/ciw741   DOI
30 Falagas ME, Tansarli GS, Karageorgopoulos DE, Vardakas KZ. Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis. 2014;20:1170-1175. https://doi.org/10.3201/eid2007.121004   DOI
31 Ahn SY, Sung JY, Kim HS, Kim MS, Hwang YJ, Jong SR, et al. Molecular epidemiology and characterization of carbapenemase-producing Enterobacteriaceae isolated at a university hospital in Korea during 4-year period. Ann Clin Microbiol. 2016;19:39-47. https://doi.org/10.5145/ACM.2016.19.2.39   DOI
32 Goodman KE, Simner PJ, Tamma PD, Milstone AM. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE). Expert Rev Anti Infect Ther. 2016;14:95-108. https://doi.org/10.1586/14787210.2016.1106940   DOI
33 Aires-de-Sousa M, Ortiz de la Rosa JM, Goncalves ML, Pereira AL, Nordmann P, Poirel L. Epidemiology of carbapenemase-producing Klebsiella pneumoniae in a hospital, Portugal. Emerg Infect Dis. 2019;25:1632-1638. https://doi.org/10.3201/eid2509.190656   DOI
34 van Duin D, Doi Y. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence. 2017;8:460-469. https://doi.org/10.1080/21505594.2016.1222343   DOI
35 Korea Centers for Disease Control and Prevention. 2017 Guidelines for management of medical-related infectious diseases (VRSA/CRE) [Internet]. Cheongju: Korea Centers for Disease Control and Prevention; 2017 [cited 2019 August 28]. Available from: http://www.cdc.go.kr/board.es?mid=a20507020000&bid=0019&act=view&list_no=138074.
36 Jeong SH, Kim HS, Kim JS, Shin DH, Kim HS, Park MJ, et al. Prevalence and molecular characteristics of carbapenemase-producing Enterobacteriaceae from five hospitals in Korea. Ann Lab Med. 2016;36:529-535. https://doi.org/10.3343/alm.2016.36.6.529   DOI